In certain embodiments, isolated or recombinant RSV containing nucleic acids and polypeptides disclosed herein (attenuated recombinant RSV or the like) is also provided, such nucleic acids suitable for use as a vaccine, a polypeptide, and immunogenic compositions comprising the RSV genome are also ...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease in young children and elderly people. Although the virus was isolated in 1955, an effective RSV vaccine has not been developed, and the only licensed intervention is passive immunoprophylaxis of high-risk infant...
Watch the latest from ITV News - RSV, Respiratory Syncytial Virus, affects 90 percent of babies and leads to many hospitalisations each year. Now, a vaccine could help bring those numbers down.
Data show the vaccine is safe, effective and has fewer side effects than if a child gets COVID-19, says Regan. "No children have died from the COVID vaccine, but we do have children that die from COVID." "If a child does test positive, they should stay home for at least five day...
STAT spoke with a number of experts to ask their advice on when people should get their shots, and whether it’s best to get two or three at once (depending on whether you qualify for an RSV vaccine), or to space the vaccines out. ...
To be effective, these treatments must be started within five to seven days of symptom onset. For more on COVID-19: The COVID winter wave has arrived. Here’s where it’s spreading during the 2024–25 holiday season Public health experts are warning of a ‘quad-demic’ this winter. ...
RSV vaccine:Adults over 60may receive a single dose following a discussion and shared clinical decision making with their provider. There is also avaccine for pregnant women,which has been recommended for women at 32 to 36 weeks' gestation, to prevent lower respiratory tract RSV infection in inf...
During a session at the Outcomes 2024 SYNC National Conference, Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed the impacts that advancements in technology have had on pharmacy. The pharmacy landscape has changed significantly over the past couple of decades, due in large par...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease in young children and elderly people. Although the virus was isolated in 1955, an effective RSV vaccine has not been developed, and the only licensed intervention is passive immunoprophylaxis of high-risk infant...
Paramyxoviruses including measles, Nipah, and parainfluenza viruses are public health threats with pandemic potential. Human parainfluenza virus type 3 (HPIV3) is a leading cause of illness in pediatric, older, and immunocompromised populations. There ar